CRVAF (CurveBeam AI) Total Stockholders Equity: $19.52 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CRVAF CurveBeam AI Ltd CRVAF
2 GF Score
Price $0.05
GF Value $0.16
! 8 Warning Signs
View Full Analysis

What is CurveBeam AI Total Stockholders Equity?

CurveBeam AI CRVAF 2 Total Stockholders Equity is $19.52 Mil as of Jun. 2026. GuruFocus rates CRVAF with a GF Score™ of 2/100 and a GF Value™ of $0.16. The stock has 8 warning signs investors should review.

CurveBeam AI's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $19.52 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. CurveBeam AI's Book Value per Share for the quarter that ended in Jun. 2026 was $0.04. The ratio of a company's debt over equity can be used to measure how leveraged this company is. CurveBeam AI's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.64.


CurveBeam AI  (OTCPK:CRVAF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

CurveBeam AI's Book Value per Share for the quarter that ended in Jun. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

CurveBeam AI's Debt-to-Equity for the quarter that ended in Jun. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CurveBeam AI Total Stockholders Equity Related Terms


CurveBeam AI Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for CurveBeam AI's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CurveBeam AI Total Stockholders Equity Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Total Stockholders Equity
Get a 7-Day Free Trial 0.00 -32.28 25.84 22.86 19.52

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.84 25.83 22.86 24.30 19.52
CRVAF
2GF Score
CurveBeam AI Ltd CRVAF
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $19.52 Mil mean?
CurveBeam AI (CRVAF) has a Total Stockholders Equity of $19.52 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for CurveBeam AI and its competitors.
Is CurveBeam AI's Total Stockholders Equity too high?
CurveBeam AI's current Total Stockholders Equity is $19.52 Mil. Overall, CurveBeam AI has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does CurveBeam AI's Total Stockholders Equity compare to ABT and SYK?
CurveBeam AI's Total Stockholders Equity of $19.52 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for CurveBeam AI and its competitors. CurveBeam AI's current Total Stockholders Equity is $19.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CurveBeam AI stock overvalued right now?
CurveBeam AI (CRVAF) has a current Total Stockholders Equity of $19.52 Mil. The stock's GF Value™ is $0.16, compared to a current price of $0.05 — trading 66.3% below its estimated fair value. The current Total Stockholders Equity is $19.52 Mil. CurveBeam AI's overall GF Score™ is 2/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For CurveBeam AI (CRVAF), the current Total Stockholders Equity is $19.52 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CurveBeam AI (CRVAF) Overvalued in 2026?

Based on GuruFocus' analysis, CurveBeam AI stock appears to be undervalued. The current stock price of $0.05 is trading 66.3% below its estimated GF Value™ of $0.16.

Key valuation signals for CRVAF:

  • Total Stockholders Equity: $19.52 Mil
  • GF Value™: $0.16 vs. price of $0.05 (66.3% below fair value)
  • GF Score™: 2/100 with 8 warning signs

No single metric tells the full story. See the CRVAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CurveBeam AI Business Description

Other Exchanges CVB:Australia
Address 10 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.
2GF Score

Get the complete analysis for CRVAF

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price
$0.16
GF Value